TNFAIP3 upregulation was associated with the activation of “maturity onset diabetes of the young”, whereas its downregulation correlated with “glycerolipid metabolism” and “nature killer cell mediated cytotoxicity”. The gene discussed is TNFAIP3; the disease is type 2 diabetes mellitus.